Biocomposites

Mar 03, 2025

Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth

Oct 16, 2024

Biocomposites invests in InfectoTest GmbH - developers of a bacterial-specific point-of-care test for periprosthetic joint infection (PJI)

Sep 23, 2024

Biocomposites to showcase innovations in infection management at EBJIS 2024

Sep 18, 2024

Biocomposites acquires remaining shares in manufacturers of SYNICEMTM and Subiton products

Sep 12, 2024

Biocomposites to distribute its NanoBone® product range in the UK

Mar 13, 2024

Biocomposites announces approval of STIMULAN in Brazil as an antibiotic carrier for treating bacterial infection

Feb 07, 2024

Biocomposites announces two new Phase II clinical trials of STIMULAN VG - a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin - in the U.S.

Jan 16, 2024

Biocomposites expands its international presence by opening new sales and distribution office in Italy

Jan 04, 2024

Biocomposites' investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2

Jun 18, 2020

Biocomposites Announces STIMULAN® Products Added to NHS Supply Chain

Apr 15, 2020

Biocomposites Appoints President, Biocomposites Inc.